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Abstract: Mosquitoes transmit several human- and animal-pathogenic alphaviruses (Togaviridae 
family). In alphavirus-infected mosquito cells two different types of virus-specific small RNAs are 
produced as part of the RNA interference response: short-interfering (si)RNAs and 
PIWI-interacting (pi)RNAs. The siRNA pathway is generally thought to be the main antiviral 
pathway. Although an antiviral activity has been suggested for the piRNA pathway its role in host 
defences is not clear. Knock down of key proteins of the piRNA pathway (Ago3 and Piwi5) in Aedes 
aegypti-derived cells reduced the production of alphavirus chikungunya virus (CHIKV)-specific 
piRNAs but had no effect on virus replication. In contrast, knock down of the siRNA pathway key 
protein Ago2 resulted in an increase in virus replication. Similar results were obtained when 
expression of Piwi4 was silenced. Knock down of the helicase Spindle-E (SpnE), an essential 
co-factor of the piRNA pathway in Drosophila melanogaster, resulted in increased virus replication 
indicating that SpnE acts as an antiviral against alphaviruses such as CHIKV and the related 
Semliki Forest virus (SFV). Surprisingly, this effect was found to be independent of the siRNA and 
piRNA pathways in Ae. aegypti cells and specific for alphaviruses. This suggests a small 
RNA-independent antiviral function for this protein in mosquitoes. 
Keywords: RNA interference; antiviral responses; Ae. aegypti; alphavirus 
 
1. Introduction 
In the last decade chikungunya virus (CHIKV; family Togaviridae, genus Alphavirus) has caused 
epidemic outbreaks in Africa, Asia, and more recently the Americas as well as sporadic outbreaks in 
Europe [1]. The symptoms are high fever, joint pain, and rash; often chikungunya infection also 
causes long term chronic diseases [1–3]. CHIKV is transmitted by the Aedes albopictus and Ae. aegypti 
mosquitoes; the latter is also an important vector for other arboviruses in the Flaviviridae family like 
the dengue virus (DENV; genus Flavivirus) and Zika virus (ZIKV; genus Flavivirus) [1]. Arbovirus 
infections in mosquitos and mosquito cell cultures are believed to be mainly asymptomatic and 
persistent, possibly due to an effective innate immune responses including the RNA interference 
(RNAi) pathway [4,5]. Of these, the short-interfering (si)RNA pathway is considered to be the main 
antiviral mechanism. It is initiated by virus-specific double-stranded (ds)RNA cleavage carried out 
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by Dicer-2 (Dcr2), producing 21 nt long dsRNA fragments called siRNAs which are loaded into 
Argonaute-2 (Ago2), a member of the RNA-induced silencing complex (RISC) [4,5]. In RISC, one of 
the complementary strands of the virus-specific siRNA (vsiRNAs) is degraded and the remaining 
strand directs Ago2 to a complementary (viral) RNA target, resulting in (viral) RNA cleavage and 
degradation [6–8]. Knock down and knock out experiments have shown that Dcr2 and Ago2 are 
antiviral against various arboviruses in mosquitoes [9–15]. 
In addition to vsiRNAs, virus-specific PIWI-interacting (pi)RNAs have been reported in 
mosquitoes (and mosquito-derived cell lines) after infection by viruses of all major arbovirus 
families [14,16–23]. piRNAs are 24–29 nt in length and produced in a Dicer-independent manner. 
Most knowledge of the piRNA pathway is based on the Drosophila melanogaster model where it is 
mainly active in germ line cells controlling transposons [24]. In contrast, in mosquitoes piRNAs are 
also produced in somatic cells and can be transposon-, gene- or virus-specific [19,25,26]. Based on the 
D. melanogaster ping-pong piRNA production model, primary piRNAs are produced initially from 
long RNA transcripts transcribed from “piRNA clusters” in heterochromatin; following cleavage 
primary piRNAs with uridine at position 1 (U1) are produced and bound by Piwi or Aubergine 
(Aub) proteins [24,27]. Primary piRNAs target sequence-specific transposon-based RNA, resulting 
in the production of secondary piRNAs with adenine at position 10 (A10) and bound to Ago3. In 
turn, these secondary piRNAs target antisense RNAs, resulting in the production of primary-type 
secondary piRNAs (again bound to Piwi or Aub) [28]. Although ping-pong amplification of 
transposon based piRNAs have been reported in Ae. aegypti, differences in the key proteins of the 
piRNA pathway have been observed between the fly and Ae. aegypti, possibly due to expansion in 
the Piwi protein family in Ae. aegypti [14,25]. 
It is currently not known what initiates the production of virus-specific piRNA (vpiRNA) in 
mosquitoes and their exact role in the control of virus replication. Previous studies indicated that, at 
least in the case of the Sindbis virus (SINV; family Togaviridae, genus Alphavirus) and DENV, Ago3 
and Piwi5 (and to a lesser extent Piwi6) are responsible for the production of vpiRNAs. The antiviral 
potentiality of piRNAs has been studied with the Semliki Forest virus family (SFV; Togaviridae, 
genus Alphavirus); knock down of Ago3 and Piwi5 results in the disappearance of SFV specific 
piRNAs [14,16,29], but it does not enhance SFV replication [14,29]. Similarly, a study conducted with 
the mosquito-borne Bunyamwera virus (BUNV; family Peribunyaviridae, genus Orthobunyavirus) 
indicated no antiviral activity of Ago3, Piwi5 and Piwi6 [20]. In contrast, Piwi4 has been reported as 
antiviral protein against SFV, BUNV, ZIKV and Rift Valley fever (RVFV, family Phenuiviridae, genus 
Phlebovirus), though it does not bind piRNAs [16,21,23,29] and is not required for the production of 
SFV-, SINV- or DENV-specific piRNAs [14,16,30]. 
In addition to these key RNAi effector proteins, other proteins are assumed to play important 
roles as co-factors of these pathways. The helicase Spindle-E (SpnE) has been shown to be essential 
for piRNA-mediated transposon silencing in D. melanogaster and required for the ping-pong 
amplification of piRNAs. It physically interacts with different piRNA pathway proteins, including 
Aub, Ago3 and Qin and thereby acts as a co-factor in the ping-pong amplification loop [31–35]. 
Moreover, mutant SpnE flies have an enhanced West Nile virus (WNV; family Flaviviridae, genus 
Flavivirus) replication and in these flies, drosophila X virus (family Birnaviridae, genus 
Entomobirnavirus) infection results in higher pathogenicity compared to control flies [36]. These 
results support an antiviral role of SpnE in the fly model; however, nothing is known about the 
possible antiviral role of SpnE in mosquitoes. Here, SpnE was found to be antiviral in Ae. aegypti 
derived cells but, surprisingly, the antiviral effects were limited to alphaviruses. Interestingly, the 
observed antiviral effect did not occur via the siRNA or piRNA pathways. 
2. Materials and Methods 
2.1. Plasmids and Viruses 
Plasmids pIZ-Fluc and pAcIE1-Rluc for luciferase sensor assay have been described previously 
[29]. Plasmid pCMV-SFV4(3H)-FFLuc, contains reporter virus cDNA based on the SFV4 clone of SFV 
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and has been described previously [29]. The reporter virus SFV4(3H)-FFLuc expresses Firefly 
luciferase as part of its non-structural polyprotein where the marker is located between nsP3 and 
nsP4 proteins and is flanked by duplicated nsP2 cleavage sites. Plasmid pCMV-SFV4 was used to 
rescue wild type SFV strain 4 [37]. CHIKV reporter virus CHIKV-2SG-FFLuc was rescued from 
cDNA plasmid pSP6-ICRES1-2SG-FFLuc. This construct is based on LR2006OPY1 stain of CHIKV 
belonging to East/Central/South African genotype [38], in this virus FFLuc is cloned between the 
non-structural and structural regions and expressed from a sub genomic promoter. Wild-type 
CHIKV was rescued from plasmid pSP6-ICRES1. Nanoluciferase-expressing BUNV (BUNV-NL) has 
been described previously [20]. The patient-derived isolate of ZIKV (strain PE243) has been described 
previously [39]. 
2.2. Cells 
Ae. aegypti-derived Aag2 cells [20] (received from P. Eggleston, Keele University, Newcastle, 
UK), were grown in L-15+Glutamax (Thermo Fisher Scientific, Waltham, MA, USA) supplemented 
with 10% Tryptose Phosphate Broth (TPB, Thermo Fisher Scientific), 10% fetal bovine serum (FBS, 
Thermo Fisher Scientific), and penicillin-streptomycin (final concentration 100 units/mL, 100 µg/mL 
respectively, Thermo Fisher Scientific) at 28 °C. Baby hamster kidney (BHK-21) cells used for 
BUNV-NL, SFV4, SFV-(3H)-FFLuc, CHIKV or CHIKV-2SG-FFLuc rescue and titration were grown 
in GMEM (Thermo Fisher Scientific) supplemented with 10% TPB, 10% FBS and 
penicillin-streptomycin (final concentration 100 units/mL, 100 µg/mL, respectively) at 37 °C in 5% 
CO2 atmosphere. A549-Npro cells [39] (obtained from R. E. Randall, University of St. Andrews, St. 
Andrews, United Kingdom) were grown in DMEM (Thermo Fisher Scientific), supplemented with 
10% FBS and used to grow and titrate ZIKV. 
2.3. cDNA Synthesis and RT-PCR 
Trizol (Thermo Fisher Scientific) was added to 1.5×105 Aag2 cells per well of a 24-well plate, 
material from two wells was then combined to isolate total cellular RNA and purification conducted 
according to the manufacturer’s instructions. 1.5 µg of total RNA was used for cDNA synthesis 
using Superscript III reverse transcriptase (Thermo Fisher Scientific) and oligo(dT)15 primer 
(Promega, Madison, WI, USA). Semi-quantitative RT-PCR for Ae. aegypti transcripts was performed 
using gene-specific primers (Supplementary Table S1, in Supporting Information) and GoTaq DNA 
polymerase (Promega); actin transcripts were used as internal control. 
2.4. Small RNA Sequencing and Sequence Analysis 
Using Trizol reagent as per manufacturer’s protocol total RNA was extracted from 2×106 virus 
infected Aag2 cells grown in T-25 flask. Small RNAs of 15–40 nt in length were gel purified and 
sequenced on an Illumina HiSeq 4000 at BGI Tech (Hong Kong, China). Obtained sequence reads 
were aligned to the SFV genome using in-house established BLAST guided bioinformatics pipeline, 
maximum of one mismatch or indel was allowed in the alignments. Reads that matched to the 
reference genome with 18 bp to 35 bp in length were further analysed. These were separated into 
two groups: positive and negative based on their alignment to the genome and antigenome, 
respectively [23]. Small RNA sequencing data is available upon request. 
2.5. Small RNA Analysis by Northern Blot 
Northern blot analysis was conducted as described previously [29,40]. In short, total RNA was 
isolated from the SFV or CHIKV infected Aag2 cells (2×106 cells, MOI 10, 48 hpi) by using Trizol 
reagent. 15µg of RNA was size-fractioned on a 0.5× TBE, 7 M Urea, 15% polyacrylamide gel, 
thereafter transferred to Hybond NX nylon membranes (GE Healthcare, Chicago, IL, USA). RNA 
was chemically cross-linked to membrane by using 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (Sigma, St. Louis, MO, USA). SFV or CHIKV-specific small RNAs were probed with a 
set of DNA oligonucleotides (Supplementary Table S1) that were 5’ end-labelled with [32P] 
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γ-adenosine-triphosphate (Perking Elmer, Waltham, MA, USA) using T4 Polynucleotide kinase 
(New England Biolabs, Ipswich, MA, USA). Hybridization of membranes with 
oligonucleotide-probes was performed overnight at 42 °C in Ultrahyb Oligo hybridization buffer 
(Thermo Fisher Scientific). Membranes were washed twice at 42 °C with each of the following three 
buffers: 2× SSC and 0.5% SDS, 2× SSC and 0.2% SDS, 0.2× SSC and 0.2% SDS. The membrane was 
exposed to a phosphoimager screen for signal detection and quantification. 
2.6. Transfection of Nucleic Acids and Virus Infections 
For transfections, 1.5×105 Aag2 cells were seeded per well of a 24-well plate and were 
transfected using 2 µL of Dharmafect 2 reagent (GE Healthcare). To silence host transcripts, 300 ng of 
gene-specific dsRNAs per well were transfected into Aag2 cells, followed by virus infections at 24 h 
post-transfection (pt). Alternatively, for RNAi reporter assays, 24 h pt 10 ng of dsRNA (FFLuc 
specific or mCherry specific) or 1 ng siRNA (targeting FFLuc or Hygromycin B resistance gene) were 
co-transfected with 50 ng of pIZ-Fluc and 50 ng of pAcIE1-Rluc plasmids; the FFLuc and Rluc 
activities were measured at 24 h pt. For small RNA sequencing analysis or northern blot analysis, 
Aag2 cells were grown in T-25 flask and transfected with 3 µg of gene-specific dsRNA using 10 µL of 
Dharmafect 2, followed by virus infection at 24 h pt. 
2.7. dsRNA Production 
Gene-specific primers flanked by T7 RNA polymerase promoter sequences were used to 
amplify unique gene-specific fragments that were validated through Sanger sequencing. PCR 
products were then used for in vitro transcription using the RNAi Megascript kit (Thermo Fisher 
Scientific) according to manufacturer’s instructions. The obtained RNAs were treated with Dnase1 
and RNaseA and purified using columns provided with the kit. Previously described and verified 
dsRNAs were used for silencing of Ago2, Piwi4, Piwi5, Piwi6, Ago3, mCherry and eGFP 
[14,20,21,29]; alternatively new silencing dsRNAs were developed (see Supplementary Table S2). 
2.8. Luciferase Assays 
Cells were lysed with passive lysis buffer (Promega) and Firefly luciferase activity measured by 
using the Luciferase Assay System (Promega) for SFV4(3H)-FFLuc, the Steady-Glo luciferase assay 
(Promega) for CHIKV-2SG-FFLuc and the Nano luciferase assay (Promega) for BUNV-NL infected 
cells. To measure both Firefly and Renilla luciferases in RNAi sensor assays, the Dual Luciferase 
Reporter Assay System (Promega) was utilised. Luciferase activities were determined in a Glomax 
luminometer. 
3. Results 
Since Piwi4 acted antivirally against different arboviruses, we hypothesized that other proteins 
possibly involved in the piRNA pathway could be antiviral, too [14,21]. To determine the antiviral 
activity of these proteins in mosquito cells, dsRNA-based knock down experiments can be used to 
determine their effects on viral replication. Therefore, homologs of selected D. melanogaster proteins, 
known to act in different parts of the piRNA pathway, were identified in Ae. aegypti using the BLAST 
algorithm (Supplementary Table S2) [28,35,41–49]. In D. melanogaster Qin, Vasa and SpnE are needed 
for proper loading of the piRNAs during the ping-pong amplification between Piwi/Aub and Ago3. 
Zucchini (Zuc), Armitage (Arm) and GasZ is thought to be involved in the producing of primary 
piRNAs and trimming of piRNAs. Hen-1 carries out methylation of mature piRNAs at their 3’ 
termini [28,35,41–46]. Hp1a, Blm and Recq4 are involved in heterochromatin silencing, including the 
regions that contain “piRNA clusters” [14,47,48]. Mutations of Arm have led to increased 
susceptibility to viral infection in D. melanoaster [49]. To test gene expression of homologues of these 
candidates in Aedes aegypti, total cellular RNA was isolated from Ae. aegypti-derived Aag2 cell lines 
and subjected to cDNA synthesis. Gene-specific primers were used to verify the expression of the 
genes of interest, followed by sequencing verification. Afterwards, gene-specific primers with T7 
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RNA polymerase binding sides, were used to amplify a unique region of the transcript to obtain 
PCR fragments that were used to synthesize gene specific dsRNAs by in vitro transcription. 
Following this, gene-specific dsRNAs or eGFP specific dsRNA (as control) were transfected to 
silence target transcripts (Figure 1A) in Aag2 cells. 24 h later, transfected cells were infected with 
firefly luciferase (FFLuc) expressing SFV4(3H)-FFLuc [29] at a multiplicity of infection (MOI) of 0.01. 
At 48 h post-infection (hpi), cells were lysed and FFLuc levels determined. Knock down of Piwi4 was 
used as positive control and confirmed the previously reported increase in luciferase levels [14]. 
From genes analysed in this experiment, transfection of SpnE-specific dsRNA, resulted in more than 
2-fold increased luciferase levels compared to the control; supporting the antiviral activity of SpnE 
against SFV (Figure 1B). The effect of other gene knock down was less prominent or not significant. 
Interestingly, transfection of GasZ specific dsRNA was the only one that resulted in a decrease of 
luciferase expression. 
 
Figure 1. Effect of knock down of piRNA-related transcripts in Aag2 cells on SFV. Aag2 cells were 
transfected with unique, gene-specific dsRNAs against Piwi4 (positive controls) and potential 
piRNA pathway proteins. (A) Knock down of Ae. aegypti homologs of Drosophila transcripts of the 
piRNA pathway using dsRNA (dseGFP as control). Gene-specific primers were used to confirm 
silencing and an actin PCR product was used as internal control; (B) Aag2 cells transfected with gene 
specific dsRNAs (dsRNA against eGFP was used as negative control) were infected with 
FFLuc-expressing SFV (MOI 0.01) and cells lysed 48 hpi. FFLuc activities were measured and 
normalized to these from control cells (taken as 1); the dotted line represents the threshold level of at 
least a two-fold increase in luciferase levels. The mean values and standard error of three 
experiments conducted independently in triplicate are shown; * denotes p < 0.05 (according to 
Student’s t-test). 
To determine if the antiviral effect of SpnE could be observed for a related alphavirus, similar 
knock down experiments were performed with CHIKV. Since less is known about the interactions of 
the mosquito RNAi response and CHIKV, it was important to perform some base line experiments 
with CHIKV in Aag2 cells. It was previously shown that CHIKV-infected cells and mosquitoes 
produced CHIKV specific siRNA and piRNAs, and that the majority of the vpiRNAs mapped to the 
final third of the genome; the region encoding for the structural proteins [19]. Moreover, knock 
down of the siRNA pathway key protein Ago2 resulted in an increased CHIKV replication in Ae. 
aegypti-derived cells and mosquitoes [11]. However, there are no data on the possible antiviral effects 
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of Piwi proteins during CHIKV infection. To assess this, Aag2 cells were transfected with previously 
validated and tested dsRNAs [14,20,21,23] against eGFP (negative control), Ago2 (positive control), 
Piwi4, Ago3, Piwi5, Piwi6 and SpnE. Transfected cells were infected with FFLuc expressing CHIKV 
(CHIKV-2SG-FFLuc (Figure 2A) at MOI of 0.01 and luciferase levels determined at 48 hpi. At least 
2-fold increases of luciferase levels were observed following knock down of Ago2 and Piwi4. The 
increase was smaller in Ago3 knock down cells and not significant upon knock down of Piwi5 or 
Piwi6. Moreover, knock down experiments with dsRNA against SpnE also showed an increase in 
luciferase levels; confirming previous results with SFV (Figure 2A). Similar results were observed for 
the production of infectious viral particles when wild type (wt) CHIKV was used (Figure 2B). 
 
Figure 2. Effect of gene silencing on CHIKV replication. (A) Aag2 cells were transfected with 
dsRNAs to silence indicated transcripts, infected with CHIKV-2SG-FFLuc at 24 h pt, and lysed at 48 
hpi. FFLuc activities were determined and are presented as relative mean luciferase activity values 
(normalized to activity in dseGFP treated). The error of the mean from three experiments conducted 
in triplicate are shown; (B) cells transfected as described above were infected with wt CHIKV at MOI 
of 0.01, and media was harvested 48 hpi, followed by plaque titration. The mean values of four 
independent experiments with standard deviation are shown. * indicates significance, p < 0.05 
(Student’s t-test). 
To determine if the antiviral effect of SpnE is alphavirus-specific or could be broadened to 
arboviruses from other families, knock down experiments were repeated and cells infected with 
nanoluciferase reporter expressing BUNV-NL [20] or wild-type ZIKV [39]. No difference in 
nanoluciferase levels were detected in BUNV-NL infected cells (MOI 0.01) lysed 48 hpi (Figure 3A). 
Similarly, titration of ZIKV collected at 72 hpi (MOI 0.1) indicated that SpnE silencing had no 
beneficial effect (Figure 3B). In contrast, improved replication of BUNV-NL and ZIKV was observed 
in previous experiments (performed with the same experimental set up) for knock down of Piwi4 
[20,23]. Thus, the results suggested that the antiviral activity of SpnE is alphavirus-specific. 
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Figure 3. Effect of SpnE silencing on BUNV and ZIKV replication. dsRNAs were transfected into 
Aag2 cells to silence SpnE and cells treated with eGFP specific dsRNAs were used as control. At 24 
hpt cells were infected with either Nanoluc-expressing BUNV-NL or wt ZIKV. (A) Cells infected 
with BUNV-NL (at MOI of 0.01) were lysed at 48 hpi; the relative mean luciferase activity values 
(normalized to these from dseGFP treated cells), together with the error of the mean from three 
independent experiments conducted in triplicate, are shown; (B) media was harvested at 72 hpi from 
wild-type ZIKV infected (MOI of 0.1) cells and subjected titration. The mean virus titre together with 
standard error of 6 independent experiments are shown. “n. s” indicates non-significance according 
to Student’s t-test. 
It was previously suggested that SpnE affects viral replication by altering the siRNA response 
in D. melanogaster [36]. Moreover, SpnE has been reported to interact with proteins of the fly piRNA 
pathway and is critical for piRNA amplification [31–35]; however, piRNAs are not antiviral in flies 
[50]. 
To study the involvement of SpnE in the siRNA-based silencing in mosquitoes, luciferase 
sensor assays were carried out. In a first step, Aag2 cells were transfected with dsRNAs targeting 
eGFP (as negative control), Ago2 (positive control), Piwi4 or SpnE. In the second step, FFLuc 
expressing plasmid (pIZ-Fluc) and Renilla luciferase (Rluc) expressing construct (pAcIE1-Rluc, used 
as internal control), were co-transfected with siRNAs targeting FFLuc or Hygromycin B resistance 
gene (Hyg) (negative control). 
Reduced levels of FFLuc were observed in dseGFP treated cells transfected with siFFLuc, 
compared to cells treated with siHyg (Figure 4A). As expected, knock down of the siRNA pathway 
key protein Ago2 resulted in reduced silencing efficiency of FFLuc-specific siRNAs (Figure 4A). At 
the same time, silencing of Piwi4 had no effect on FFLuc silencing; confirming previous results that 
Piwi4 did not act via the siRNA pathway [29] (Figure 4A). Similarly, SpnE silencing did not affect the 
efficiency of siRNA-based silencing of FFLuc in Aag2 cells (Figure 4A). 
 
Figure 4. Effect of SpnE knock down on the siRNA pathway based silencing efficiency. Aag2 cells 
were first treated with dsRNA against eGFP (control), Ago2, Piwi4 or SpnE. 24 h later the cells were 
co-transfected with FFLuc and Rluc expressing reporter plasmids (pIZ-Fluc and pAcIE1-Rluc) and 
siRNAs against FFLuc (siFFLuc) or Hygromycin B (siHyg) (A) to assess the silencing ability of 
pre-formed siRNAs in the cells, or alternatively dsRNAs targeting FFLuc (dsFFLuc) or mCherry 
(dsmCherry) (B) to assess the silencing ability of siRNAs produced in a Dcr2-dependent manner. 
Cells were lysed at 24 hpt and activities of luciferases determined. Relative luciferase levels are 
shown on the Y-axis (with FFLuc/Rluc ratio in siHyg or dsmCherry transfected cells set to 1). The 
mean values with standard error are shown for three independent experiment conducted in 
triplicate, * shows p < 0.05 using two-way ANOVA. 
During virus infection vsiRNAs are produced from long dsRNAs by Dcr2-mediated cleavage, 
thus it was important to control whether silencing of SpnE could affect dsRNA processing into 
functional siRNAs. A dsRNA-based reporter assay was performed in Aag2 cells, similar to the 
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previous described siRNA-based RNAi reporter assay. Therefore, Aag2 cells previously treated with 
dsRNA against Ago2, Piwi4, SpnE or eGFP (negative control) were co-transfected with pIZ-Fluc, 
pAcIE1-Rluc plasmids and dsRNAs targeting mCherry (negative control) or FFLuc. Again, knock 
down of Ago2 significantly decreases the dsRNA-based silencing of FFLuc gene (Figure 4B). In 
contrast, neither silencing of Piwi4 nor SpnE disrupted dsRNA-based silencing of FFLuc reporter 
(Figure 4B). These experiments suggest that SpnE did not affect the siRNA pathway in mosquito 
cells, and thus the antiviral activity of SpnE was not due to interactions with the siRNA pathway. 
To detect if SpnE affects the production of viral specific, vpiRNAs, Aag2 cells treated with 
dsRNAs against eGFP, Ago3, Piwi5, Piwi6 and SpnE were infected with SFV or CHIKV at a MOI of 
10 and total cellular RNA isolated at 48 hpi. Total RNA was size-separated on gel, transferred onto 
Nylon membrane and probed for virus-specific small RNAs. As previously reported, silencing of 
Ago3 and Piwi5 resulted in almost complete disappearance of SFV-specific piRNAs, supporting 
their involvement in the SFV-specific vpiRNA production. In contrast, only a modest 60% or 30% 
reduction in SFV-specific piRNAs was detected in Piwi6 or SpnE silenced cells compared to control 
cells, respectively. Similar results were obtained with CHIKV, where knock down of Ago3 and Piwi5 
resulted in nearly complete loss of vpiRNA production. Again, Piwi6 and SpnE knock down only 
diminished vpiRNA amounts by approximately 50% (Figure 5). 
 
Figure 5. Northern blot analysis of virus-specific piRNAs. Aag2 cells were transfected with dsRNAs 
against Ago3, Piwi5, Piwi6, SpnE or eGFP (as negative control). 24 h pt the cells were infected with 
wt SFV (A) or wt CHIKV (B) at a MOI of 10. Total RNA isolated at 48 hpi was separated on 
PAGE-Urea gel, transferred onto nylon membrane and probed with virus specific radiolabelled 
DNA oligos for piRNAs and siRNAs. In the left panel, a representative image of three independent 
experiments is shown; in the right panel the mean levels of three independent experiments with 
standard deviation of SFV- or CHIKV-specific vpiRNAs are shown, * indicates significance, p < 0.05 
(Student’s t-test); vpiRNA levels in control dseGFP treated cells taken as 100%. 
The effect of SpnE silencing on total SFV specific vpiRNA levels and their distribution was 
further characterized by small RNA sequencing (Figure 6, Supplementary Table S3). Previous 
studies by us have indicated that SFV-specific vpiRNA production is dependent on Ago3 and Piwi5 
[14,29].Their knock down resulted in overall reduction in the number of sense and antisense 
strand-specific piRNAs, though there was no change in distribution along the genome/antigenome. 
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Consistent with data from previous experiments, knock down of SpnE indeed reduced the total 
production of SFV-specific vpiRNAs (Figure 6A) to about 30% compared to the levels in control cells 
that were transfected with dsRNAs against eGFP (Figure 6A, Supplementary Table S3). No changes 
in the overall vsiRNAs amounts, nor their distribution along genome and antigenome (Figure 6A,B) 
were detected in SpnE silenced cells. Knock down of SpnE did not affect the vsiRNA distribution 
(Figure 6B), and despite the slightly reduced amounts of vpiRNAs, genome or antigenome mapping 
of these small RNAs was also unaltered (Figure 6C). vpiRNAs showed an A10 or U1 bias dependent 
on location on the genome or antigenome, respectively (Figure 6D). 
 
Figure 6. Analysis of SFV-specific small RNAs from Aag2 cells. dsRNAs were used to knock down 
eGFP (Left panel, as control) or SpnE (Right panel) in Aag2 cells. At 24 h pt cells were infected with 
SFV at an MOI of 10. At 48 hpi total RNA was isolated and small RNAs collected and sequenced. (A) 
Size distribution of small RNA sequences mapping to the SFV genome (red) or antigenome (green) 
(as percentage of total reads). Distribution of 21 nt (B) or 27 nt (C) long RNAs along the SFV genome 
(red, positive numbers on Y axis) or antigenome (green, negative numbers on Y axis); (D) relative 
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nucleotide frequency and conservation per position of the 24- to 29-nt long piRNAs mapping to the 
SFV genome or antigenome; as DNA template was used for sequencing, U is represented by T. 
Since the majority of piRNAs are transposon-specific, we tested if SpnE can affect their levels. 
We focused our analysis on the top 50 piRNA producing transposonsable elements (TE) according to 
Miesen et al. [16]. In our dataset piRNAs could be mapped to all 50 transposons, however, the 
number of reads for two of them was too low, thus these transposon-specific piRNAs were excluded. 
The majority of transposon-specific piRNAs were of antisense polarity (Supplementary Table S4) 
and 18 transposons produced enough sense strand specific reads for further analysis. These results 
indicated that on average SpnE knock down had no effect on total piRNA production. However, 
SpnE silencing reduced the sense strand specific piRNAs for 5 of the studied transposons, though 
the reduction was moderate (between 30–45%). Overall, these results suggest that the 
alphavirus-specific antiviral activity of SpnE is not directly linked to the small RNA pathways nor 
that SFV- or CHIKV-specific piRNAs are antiviral in the performed experimental set up. 
4. Discussion 
Initially in D. melanogaster, SpnE was found to be required for microtubule network formation, 
RNA localization and embryonic pattern formation, later it was also found to be associated with the 
piRNA pathway, SpnE has DExH helicase and Tudor domains and in D. melanogaster, SpnE has been 
shown to associate with Vasa, Qin, Aub and Ago3 where it is involved in the ping-pong 
amplification loop of transposon-specific piRNAs [31–35,51]. Moreover, SpnE cycles between the 
cytoplasm and the so-called nuage structures. Nuage structures are close to the cytoplasmic face of 
nuclear pores and are sites where the ping-pong cycle occurs and TE silencing takes place. These 
reports indicated that SpnE was not required for nuage assembly and that SpnE was required for 
maintenance of Aub and Ago3 protein levels, but not for transcription of these genes [35,52]. In D. 
melanogaster mutant for SpnE WNV replication increased compared to control flies which suggested 
an antiviral activity of SpnE in this model via a RNAi-dependent mechanism; however, this was not 
directly shown [36]. 
Little is known about the role of piRNA pathway proteins in mosquitoes. In contrast to D. 
melanogaster which express Piwi, Aub and Ago3, Ae. aegypti lacks Aub, but encodes Ago3 and an 
expansion of PIWI proteins (1-7 PIWI proteins) [14,25]. In the fly model piRNAs are produced only 
in germ line or ovarian sheet cells [53], whereas in mosquitoes piRNAs are also produced in somatic 
tissues [19]. Moreover, piRNAs in D. melanogaster appear not to act antivirally [50]. In the current 
study, it was established that infected mosquito cells produce CHIKV-specific piRNAs in a similar 
fashion to previously studied alphaviruses: SFV and SINV [14,16,29]. Knock down of Ago3 or Piwi5 
results in disappearance of vpiRNAs, supporting their role in the ping-pong based piRNA 
production. However, as previously shown for SFV, knock down of Ago3 and Piwi5 had no 
significant effect on CHIKV infection. In contrast, knock down of Piwi4 resulted in increased CHIKV 
replication, similar to previous reports for other arboviruses, including BUNV, SFV and ZIKV 
[14,20,21,23]. However, Piwi4 does not bind piRNAs at all nor is it involved in SINV- or SFV-specific 
piRNA production [16,26,29]. 
We conducted a screen where we silenced—by using gene-specific dsRNAs—potential piRNA 
pathway proteins in Aag2 cells. With any knock down experiment there is likelihood of false 
negatives, and reduced RNA levels may not result in reduced protein levels. Regardless, knock 
down of SpnE resulted in increased replication of CHIKV and SFV, but not of BUNV and ZIKV, 
indicating that SpnE acts as an alphavirus specific antiviral protein in mosquito cells. Its mode of 
action is still unclear; however, the effects were not directly linked to the siRNA pathway. Neither is 
its antiviral activity strongly linked to the vpiRNA production; although it should be noted that 
SpnE (like Piwi6) knock down partly reduced SFV and CHIKV specific piRNA levels. Yet, almost 
complete loss of vpiRNA production (if Ago3 and Piwi5 were silenced) did not benefit SFV 
replication [14,29] or CHIKV replication (current study). Moreover, knock down of SpnE only 
affected a small number of (tested) transposon-specific piRNA. 
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Taken together the results indicate that SpnE is an antiviral protein, specifically for alphavirus 
infected mosquito cells and its activity is not mediated by the siRNA or piRNA pathway. More 
research is needed to understand the precise antiviral mode of action of SpnE in Ae. aegypti. SpnE is 
one of the proteins involved in the RNA metabolism and it may be that the antiviral activity is linked 
to such pathways, rather than RNAi. 
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/10/2/88/s1. 
Table S1: Oligos for northern blot. Table S2: Primers sequences. Table S3: Small RNA sequencing reads. Table 
S4: Transposon-specific small RNA reads 
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